Cite
Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials involving 2624 patients.
MLA
Tanashat, Mohammad, et al. “Effects of Dapagliflozin and Empagliflozin on 6-Min Walk Distance in Heart Failure with Preserved and Reduced Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Involving 2624 Patients.” European Journal of Clinical Pharmacology, vol. 80, no. 7, July 2024, pp. 951–63. EBSCOhost, https://doi.org/10.1007/s00228-024-03660-2.
APA
Tanashat, M., Manasrah, A., & Abouzid, M. (2024). Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials involving 2624 patients. European Journal of Clinical Pharmacology, 80(7), 951–963. https://doi.org/10.1007/s00228-024-03660-2
Chicago
Tanashat, Mohammad, Almothana Manasrah, and Mohamed Abouzid. 2024. “Effects of Dapagliflozin and Empagliflozin on 6-Min Walk Distance in Heart Failure with Preserved and Reduced Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Involving 2624 Patients.” European Journal of Clinical Pharmacology 80 (7): 951–63. doi:10.1007/s00228-024-03660-2.